Alessandro Soria

2.5k total citations · 1 hit paper
40 papers, 739 citations indexed

About

Alessandro Soria is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Alessandro Soria has authored 40 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Infectious Diseases, 20 papers in Virology and 10 papers in Epidemiology. Recurrent topics in Alessandro Soria's work include HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (14 papers). Alessandro Soria is often cited by papers focused on HIV Research and Treatment (20 papers), HIV/AIDS drug development and treatment (18 papers) and HIV/AIDS Research and Interventions (14 papers). Alessandro Soria collaborates with scholars based in Italy, United States and Israel. Alessandro Soria's co-authors include Maria Grazia Valsecchi, Adriano Lazzarin, Paolo Bonfanti, Andrea Gori, Laura Antolini, Silvia Mori, Giuseppe Foti, Ernesto Contro, Giacomo Bellani and Grazia Messinesi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Alessandro Soria

38 papers receiving 719 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study

2020 307 citations Alessandro Soria, Paolo Bonfanti et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alessandro Soria Italy	12	316	248	248	147	127	40	739
Glenn Eiger United States	16	156 0.5×	195 0.8×	96 0.4×	113 0.8×	69 0.5×	48	786
Marco Zampoli South Africa	17	227 0.7×	49 0.2×	351 1.4×	52 0.4×	31 0.2×	65	759
N. Mémain France	9	371 1.2×	41 0.2×	65 0.3×	92 0.6×	29 0.2×	16	685
Brandon M Carius United States	9	131 0.4×	32 0.1×	24 0.1×	81 0.6×	64 0.5×	48	368
Nitipatana Chierakul Thailand	14	212 0.7×	26 0.1×	210 0.8×	28 0.2×	26 0.2×	44	556
Julián Olalla Spain	12	232 0.7×	64 0.3×	86 0.3×	104 0.7×	23 0.2×	69	534
Amélie Menard France	11	261 0.8×	106 0.4×	20 0.1×	128 0.9×	23 0.2×	26	497
Aoife G. Cotter Ireland	14	448 1.4×	206 0.8×	17 0.1×	412 2.8×	21 0.2×	43	825
Vito D’Andrea Italy	16	121 0.4×	9 0.0×	177 0.7×	46 0.3×	98 0.8×	59	825
Sergio Reus Spain	14	253 0.8×	124 0.5×	19 0.1×	128 0.9×	19 0.1×	64	633

Countries citing papers authored by Alessandro Soria

Since Specialization

Citations

This map shows the geographic impact of Alessandro Soria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Soria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Soria more than expected).

Fields of papers citing papers by Alessandro Soria

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandro Soria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Soria. The network helps show where Alessandro Soria may publish in the future.

Co-authorship network of co-authors of Alessandro Soria

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Soria. A scholar is included among the top collaborators of Alessandro Soria based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Soria. Alessandro Soria is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iavarone, Massimo, Massimo Puoti, Hamid Hasson, et al.. (2025). Comparable 5‐Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study. Liver International. 45(12). e70437–e70437.

Rossotti, Roberto, Alessandro Tavelli, Anna De Bona, et al.. (2024). Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition. AIDS and Behavior. 28(7). 2258–2263. 2 indexed citations

Castelli, Francesco, Antonio Di Biagio, Antonella d’Arminio Monforte, et al.. (2023). Influence of efavirenz and 8‐hydroxy‐efavirenz plasma levels on cognition and central nervous system side effects. HIV Medicine. 25(4). 491–497. 2 indexed citations

Bresciani, Elena, Nicola Squillace, Valentina Orsini, et al.. (2022). miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis. International Journal of Molecular Sciences. 23(7). 3486–3486. 4 indexed citations

Rossotti, Roberto, Alessandro Tavelli, Stefano Bonora, et al.. (2020). Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. Digestive and Liver Disease. 52(4). 447–451. 1 indexed citations

Fabbiani, Massimiliano, Nicoletta Ciccarelli, Valeria Castelli, et al.. (2019). Hepatitis C virus–related factors associated WITH cognitive performance in HIV-HCV-coinfected patients. Journal of NeuroVirology. 25(6). 866–873. 7 indexed citations

Squillace, Nicola, Daria Trabattoni, Antonio Muscatello, et al.. (2018). Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen. Journal of Antimicrobial Chemotherapy. 73(8). 2162–2170. 8 indexed citations

Soria, Alessandro, Massimiliano Fabbiani, Giuseppe Lapadula, & Andrea Gori. (2017). Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct‐acting antivirals. Hepatology. 66(3). 992–994. 10 indexed citations

Lapadula, Giuseppe, Davide Paolo Bernasconi, Salvatore Casari, et al.. (2016). Risk of Chronic Kidney Disease among Patients Developing Mild Renal Impairment during Tenofovir-Containing Antiretroviral Treatment. PLoS ONE. 11(9). e0162320–e0162320. 32 indexed citations

10.

Ripa, Marco, Manuela Pogliaghi, Stefania Chiappetta, et al.. (2016). Maraviroc in addition to cART during primary HIV infection: Results from MAIN randomized clinical trial and 96-weeks follow-up. Journal of Clinical Virology. 85. 86–89. 1 indexed citations

11.

Soria, Alessandro, Daria Trabattoni, Nicola Squillace, et al.. (2015). Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4+ T-Cell Counts at Presentation: The IMMUNEF Clinical Trial. PLoS ONE. 10(2). e0117118–e0117118. 3 indexed citations

12.

Mangioni, Davide, Alessandro Soria, Laura Brighina, et al.. (2014). A case of classic neuromyelitis optica (Devic’s syndrome) triggered by pegylated-interferon α. BMC Pharmacology and Toxicology. 15(1). 56–56. 6 indexed citations

13.

Soria, Alessandro, Franca Rosa Guerini, Alessandra Bandera, et al.. (2011). KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy. PLoS ONE. 6(11). e27349–e27349. 24 indexed citations

14.

Lapadula, Giuseppe, Alessandro Soria, Alessandra Bandera, et al.. (2011). Unmasking tuberculosis in the era of antiretroviral treatment. European Respiratory Journal. 39(5). 1064–1075. 11 indexed citations

15.

Nozza, Silvia, Laura Galli, Alessandro Soria, et al.. (2010). Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience. AIDS. 24(6). 924–928. 37 indexed citations

16.

Soria, Alessandro, Anna Danise, Laura Galli, et al.. (2010). Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: A pilot randomised trial. Journal of Clinical Virology. 47(3). 253–257. 5 indexed citations

17.

Bandera, Alessandra, Giulio Ferrario, Marina Saresella, et al.. (2010). CD4+ T Cell Depletion, Immune Activation and Increased Production of Regulatory T Cells in the Thymus of HIV-Infected Individuals. PLoS ONE. 5(5). e10788–e10788. 42 indexed citations

18.

Soria, Alessandro, Klaudia Porten, Laura Galli, et al.. (2008). Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients. Antiviral Therapy. 14(3). 339–347. 23 indexed citations

19.

Soria, Alessandro & Adriano Lazzarin. (2007). Antiretroviral Treatment Strategies and Immune Reconstitution in Treatment-naive HIV-Infected Patients with Advanced Disease. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(Suppl 1). S19–S30. 29 indexed citations

20.

Gianotti, Nicola, Alessandro Soria, Laura Galli, et al.. (2003). Predictors of sustained response to therapy resumption after treatment interruption in HIV‐infected patients failing antiretroviral therapy. Journal of Medical Virology. 72(2). 181–186. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact